Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor.
Francisco Javier Gil-EtayoSara GarcinuñoAntonio LaluezaRaquel Díaz-SimónAna García-ReyneDaniel Enrique PleguezueloOscar Cabrera-MaranteEdgard Alfonso Rodriguez-FriasAlfredo Perez-RivillaManuel SerranoAntonio SerranoPublished in: Biomedicines (2021)
Most COVID-19 patients would carry these aPL before the infection. At least two mechanisms could be behind thrombosis, early immune-dysregulation-mediated thrombosis after infection and belated-aPL-mediated thrombosis, with SARS-CoV-2 behaving as a second hit.